0000947871-22-000426.txt : 20220330 0000947871-22-000426.hdr.sgml : 20220330 20220330083858 ACCESSION NUMBER: 0000947871-22-000426 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20220330 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220330 DATE AS OF CHANGE: 20220330 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 22783384 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 8-K 1 ss899640_8k.htm CURRENT REPORT
0000064803 false 0000064803 2022-03-30 2022-03-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 30, 2022

 

 

CVS HEALTH CORPORATION

(Exact name of registrant as specified in its charter)

Delaware 001-01011 05-0494040
(State or other jurisdiction of
incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

     

 

One CVS Drive, Woonsocket, Rhode Island 02895
(Address of principal executive offices) (Zip Code)
   

 

Registrant’s telephone number, including area code: (401) 765-1500
Former name or former address, if changed since last report: N/A

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per share CVS New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company   ☐   

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

 

 
   

 

Section 8 – Other Events

 

Item 8.01Other Events.

 

CVS Health Corporation (“CVS Health”) issued a press release today announcing that it and its subsidiary CVS Pharmacy, Inc. (“CVS Pharmacy”) have entered into a settlement agreement with the State of Florida to resolve claims related to prescriptions for opioid medications that were filled at CVS pharmacy locations in Florida. Under the terms of the settlement agreement, CVS Health and CVS Pharmacy will settle all opioid claims against them and their subsidiaries by the State of Florida for $484 million, which is to be paid over a period of 18 years. Under the agreement, local municipalities within the State of Florida have 30 days to determine whether they will join the settlement negotiated by the State of Florida. At the conclusion of the 30-day period, CVS Health and CVS Pharmacy have the option to not proceed with the settlement if they determine that a sufficient number of municipalities have not agreed to join the settlement. As a result of this settlement, CVS Health and CVS Pharmacy will no longer be defendants in the State of Florida’s opioid lawsuit that is scheduled for trial in April 2022.

 

A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.

Section 9 – Financial Statements and Exhibits

 

  Item 9.01 Financial Statements and Exhibits.

 

(d)   Exhibits.
     
Exhibit No.   Description
99.1   Press Release, dated March 30, 2022.
104   Cover Page Interactive Data File (embedded within the Inline XBRL).

 

 

 

 

 

 

   

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    CVS HEALTH CORPORATION
     
Date:  March 30, 2022 By: /s/ Colleen M. McIntosh
    Colleen M. McIntosh
    Senior Vice President, Chief Governance Officer,
    Corporate Secretary and Assistant General Counsel

 

 

 

 

 

 

 

   
 EX-99.1 2 ss899640_ex9901.htm PRESS RELEASE

Exhibit 99.1

 

 

 

 

CVS Health Reaches Opioid Settlement Agreement with State of Florida

 

WOONSOCKET, R.I., March 30, 2022 — CVS Health (NYSE: CVS) announced today that it has entered into an agreement with the State of Florida to resolve claims dating back more than a decade related to prescriptions for opioid medications that were filled at Florida CVS Pharmacy locations.

 

Under the agreement the company will settle all opioid claims against it by Florida for $484 million, to be paid over a period of 18 years. As a result, CVS Pharmacy will no longer be a defendant in Florida’s opioid lawsuit that is scheduled for trial in April 2022.

 

“Putting these claims behind us is in the best interest of all parties and helps sharpen our focus on delivering a personalized, connected health care experience for the millions of consumers who rely on us,” said Thomas Moriarty, Chief Policy and External Affairs Officer and General Counsel, CVS Health. “We look forward to continuing our longstanding partnership with the State of Florida in providing programs, services and solutions to reduce the illegitimate use of opioid medications.”

 

The settlement amount is expected to be used by the State of Florida to support its efforts to combat opioid addiction and abuse.

 

CVS Health will continue to build on its own established efforts to fight opioid abuse, which include:

 

·Significant investments in technology and procedures to support its pharmacists in exercising their professional obligations
·Innovative, comprehensive, and industry-leading policies, procedures and controls relating to the dispensing of controlled substances
·Effective educational programs for patients and providers, as well as a Pharmacists Teach program focused on prescription drug misuse that has reached 600,000 teens and parents
·Rollout of more than 4,000 safe medication disposal units in stores and local police departments across the country, which to date have collected four million pounds of unused medication
·Installation of time delay safes in nearly 6,800 pharmacies across 23 states and Washington, DC to help deter opioid robberies
·Nationwide access in CVS Pharmacy locations to life-saving opioid overdose reversal medication

 

The settlement with the State of Florida includes no admission of wrongdoing. As a result of the unique facts and circumstances of the Florida claims, the settlement value should not be extrapolated to any other opioid-related litigation in which CVS Health is involved. CVS Health will continue to vigorously defend against other lawsuits relating to opioids.

 

###

 

 

   

 

About CVS Health

CVS Health is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and approximately 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses, and nurse practitioners. Wherever and whenever people need us, we help them with their health – whether that’s managing chronic diseases, staying compliant with their medications, or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system – and their personal health care – by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Learn more at www.cvshealth.com.

 

Media contact

Mike DeAngelis

401-770-2645

Michael.DeAngelis@CVSHealth.com

 

Investor contact

Thomas Cowhey

1-800-201-0938

Thomas.Cowhey@CVSHealth.com

 

 

 

   

 

 

 

 GRAPHIC 3 image_001.jpg GRAPHIC begin 644 image_001.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# H'!PD'!@H)" D+"PH,#QD0#PX. M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_ MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T] M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P 1" 3 &@# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#4\8^.-5M/ M$;VFGN;:*S;!!7/G'KD_[/I6>_Q*UAM:2\&U;5<*;->58=^>N?0UW'C/P?%X MCM/.MPL>HQ+^[<\!Q_=;^A[5A^!O ;VTJZGK4.V5#^XMGYVG^\WOZ#\:YW&I MS:/0]VC6P*PW-*/O)6MU?]?@.U[Q+J^J>)H-"T*7[&S(K2.XPV2NX@^F!Z=Z MHWNH^-=(M;Z"YDE9;;$BWHC!4@8R,D<@@_7(J[XET75]*\8IXBT>T-XK#+QC MD@[=IR.N",=*LZ%;>(]?U*\N-<$UIILT31K:,<*2PQP.N!RCTVZ*7][\LS!5))!V]#TR>:R3XKUR_OK MH'78["2!ML4,B[5?!P03C /'>KO@WPAJEMXHADU*UEBM[(.T;OC#-T&.?6T90CT8E>OXU+5[68 M2MD>&K2ZTVYNC!J#7A]:?>^,M+L;V>W?[5(ML<7,\- MN[Q6YQG#N!@''Y=\5QMEH-V^D6>B7UOXEDFC$<,T/GHMH%0CYQ)M^[\H( ^; MH/>MJS>_T"UU726T6[O);BYGFMIHD#13B4EAO;/RD9P<]AQFF9#F\4FXUW3; MZQN+J32KJQN)3;F#ES&5PRC&XYW'Z\53_P"$UGN+3PQK+M$VFTVZ3[-9SV4XV1EP<^F: .TT?7K36UF%N)XIH&"S6]Q$8Y8 MR1D94^HZ&BLO3EN%^(.KS/9726TUK!''.R8C9D+EN<_[8Q^-% '34444 %)1 910 M)110 M%%% !1110 4444 %%%% '_V0$! end GRAPHIC 4 image_002.jpg GRAPHIC begin 644 image_002.jpg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cvs-20220330.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 6 cvs-20220330_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 7 cvs-20220330_pre.xml XBRL PRESENTATION FILE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover
Mar. 30, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 30, 2022
Entity File Number 001-01011
Entity Registrant Name CVS HEALTH CORPORATION
Entity Central Index Key 0000064803
Entity Tax Identification Number 05-0494040
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One One CVS Drive
Entity Address, City or Town Woonsocket
Entity Address, State or Province RI
Entity Address, Postal Zip Code 02895
City Area Code 401
Local Phone Number 765-1500
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol CVS
Security Exchange Name NYSE
Entity Emerging Growth Company false
XML 9 ss899640_8k_htm.xml IDEA: XBRL DOCUMENT 0000064803 2022-03-30 2022-03-30 iso4217:USD shares iso4217:USD shares 0000064803 false 8-K 2022-03-30 CVS HEALTH CORPORATION DE 001-01011 05-0494040 One CVS Drive Woonsocket RI 02895 401 765-1500 false false false false Common Stock, par value $0.01 per share CVS NYSE false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 22 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://CVS/role/Cover Cover Cover 1 false false All Reports Book All Reports ss899640_8k.htm cvs-20220330.xsd cvs-20220330_lab.xml cvs-20220330_pre.xml ss899640_ex9901.htm image_001.jpg http://xbrl.sec.gov/dei/2021q4 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ss899640_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "ss899640_8k.htm" ] }, "labelLink": { "local": [ "cvs-20220330_lab.xml" ] }, "presentationLink": { "local": [ "cvs-20220330_pre.xml" ] }, "schema": { "local": [ "cvs-20220330.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "CVS", "nsuri": "http://CVS/20220330", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ss899640_8k.htm", "contextRef": "From2022-03-30to2022-03-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://CVS/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ss899640_8k.htm", "contextRef": "From2022-03-30to2022-03-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 16 0000947871-22-000426-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000947871-22-000426-xbrl.zip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